Skip to main content

Evaluación del riesgo cardiovascular en mujeres jóvenes después de embarazo con o sin complicaciones placentarias (Estudio CARDIOMOM).

PI22/00462

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D+i en Salud
Call year 2022
State Plan 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre IIB-SANT PAU. INSTITUTO DE INVESTIGACION HOSPITAL SANTA CRUZ Y SAN PABLO
Execution centre IIB-SANT PAU. INSTITUTO DE INVESTIGACION HOSPITAL SANTA CRUZ Y SAN PABLO

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Ophthalmic artery Doppler and carotid intima-media thickness 3-6 years postpartum in women with and without a history of placental insufficiency

  • García Manau, Pablo|||0000-0002-2415-1626
  • Platero, Judit|||0000-0001-6007-9855
  • Costa, Noah
  • Garcia, Zoraida
  • Garrido-Giménez, Carmen|||0000-0003-2180-1715
  • Pellicer, Claudia
  • Ullmo, Johana|||0000-0002-9313-917X
  • Nan, Madalina Nicoleta|||0009-0001-2794-447X
  • Mora Brugués, Josefina|||0000-0001-6777-5132
  • García Osuna, Álvaro|||0000-0002-6682-0226
  • Sánchez García, Olga|||0000-0002-5279-440X
  • Jordi, Mariona
  • Choliz, Marta
  • Cruz-Lemini, Monica|||0000-0002-6807-3578
  • Trilla, Cristina|||0000-0002-5650-1790
  • Domínguez Gallardo, Carla|||0000-0002-5365-1005
  • Llurba, Elisa|||0000-0003-4048-6407
Preeclampsia and fetal growth restriction, which are clinical presentations of placental dysfunction, are frequently associated with angiogenic imbalance during pregnancy and increased long-term cardiovascular risk. Whether this risk is driven by the pre-pregnancy risk factors, clinical disease, or by an elevated sFlt-1/PlGF ratio remains unclear. This study aimed to assess the association between vascular assessments (ophthalmic artery Doppler and carotid intima-media thickness) 3-6 years postpartum and a history of preeclampsia and fetal growth restriction, and to evaluate if associations were impacted by an angiogenic imbalance during pregnancy. This was a cross-sectional study, which included individuals prospectively recruited during their index pregnancy between 2018 and 2021 and re-evaluated 3-6 years postpartum. Preeclampsia, fetal growth restriction, and sFlt-1/PlGF values were defined from pregnancy data. Postpartum assessment included ophthalmic artery Doppler and carotid intima-media thickness performed by a single operator. Multivariable linear regression models assessed associations between placental dysfunction, angiogenic imbalance, and vascular parameters, adjusting for maternal covariates. 354 participants were included, 148 with and 206 without a history of preeclampsia or fetal growth restriction. Both placental dysfunction and angiogenic imbalance during pregnancy were independently associated with a significantly higher ophthalmic artery peak systolic velocity ratio 3-6 years postpartum. Participants with a history of placental dysfunction showed higher values compared to those without [0.75 (0.67-0.81) vs. 0.69 (0.63-0.78), p = 0.03], as did those with an elevated sFlt-1/PlGF ratio during pregnancy [0.76 (0.66-0.82) vs. 0.70 (0.64-0.78), p = 0.03]. The highest values were observed in women who had experienced both conditions. When preeclampsia and fetal growth restriction were analyzed separately, the association remained significant for preeclampsia, whereas in the fetal growth restriction group, a significant difference was observed only in the right eye. No statistically significant differences were observed in carotid intima-media thickness. Both a history of angiogenic imbalance and a clinical placental dysfunction presentation (particularly preeclampsia) during pregnancy were associated with increased ophthalmic artery peak systolic velocity ratio 3-6 years postpartum, whereas carotid intima-media thickness did not differ between the study groups. Both angiogenic imbalance and a history of placental dysfunction during pregnancy are associated with increased ophthalmic artery peak systolic velocity ratio 3-6 years postpartum, especially in cases where clinical disease (particularly preeclampsia) develops.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Long-Term Biochemical and Cardiovascular Profiles 3-6 Years After Preeclampsia, Impact of Angiogenic Imbalance During Pregnancy

  • Costa, Noah
  • Platero, Judit|||0000-0001-6007-9855
  • García Manau, Pablo|||0000-0002-2415-1626
  • Sánchez García, Olga|||0000-0002-5279-440X
  • Jordi, Mariona
  • García Ruiz, Zoraida|||0009-0009-4631-763X
  • Garrido-Giménez, Carmen|||0000-0003-2180-1715
  • Ullmo, Johana|||0000-0002-9313-917X
  • Nan, Madalina Nicoleta|||0009-0001-2794-447X
  • Mora Brugués, Josefina|||0000-0001-6777-5132
  • García Osuna, Álvaro|||0000-0002-6682-0226
  • Choliz, Marta
  • Cruz-Lemini, Monica|||0000-0002-6807-3578
  • Llurba, Elisa|||0000-0003-4048-6407
  • Pellicer, Claudia
  • Medina Mallen, Maria del Carmen|||0000-0002-1219-5947
Background/Objectives: Preeclampsia is associated with long-term cardiovascular and metabolic risks. This study aimed to evaluate metabolic and cardiovascular biochemical profiles in women with a history of preeclampsia and angiogenic imbalance during pregnancy. Methods: We conducted a cross-sectional study at Hospital de la Santa Creu i Sant Pau between August 2023 and July 2025. Participants had been prospectively enrolled during pregnancy (2018-2022) and were re-evaluated 3 to 6 years later. Blood and urine samples were collected after a 12-h fast to assess hematological, metabolic, and cardiovascular markers. Angiogenic profiles were determined using sFlt-1/PlGF ratios obtained during pregnancy. Multivariable linear regression models were used to assess associations with a history of PE and angiogenic imbalance, adjusting for relevant confounders. Results: 363 participants were included. 113 (31.1%) had a history of preeclampsia. Women with previous preeclampsia showed slightly higher high-sensitivity troponin T concentrations [4.0 (3.0-6.0) ng/L vs. 3.2 (3.0-5.0) ng/L, p = 0.03]. Women with sFlt-1/PlGF ≥38 exhibited significantly higher urinary protein [0.09 (0.07-0.18) g/L vs. 0.08 (0.07-0.13) g/L, p = 0.01], potassium [4.25 (4.07-4.40) mmol/L vs. 4.19 (4.02-4.37) mmol/L, p = 0.048], and LDH concentrations [168 (150-189) U/L vs. 163 (149-177) U/L, p = 0.046], and lower leukocyte counts [6150 (5348-7055) vs. 6250 (5430-7450) U/mL, p = 0.03]. Conclusions: Women with angiogenic imbalance during pregnancy display subtle alterations in renal and endothelial function markers years after delivery, whereas those with preeclampsia show slightly higher troponin concentrations. These findings, though clinically irrelevant, suggest that pregnancy-related vascular dysfunction may have different long-term manifestations depending on whether the maternal cardiovascular system was sufficiently compromised to develop overt preeclampsia.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

N-terminal pro B-type natriuretic peptide as biomarker to predict pre-eclampsia and maternal-fetal complications

  • Nan, Madalina Nicoleta|||0009-0001-2794-447X
  • Universitat Autònoma de Barcelona.
  • Garrido-Giménez, Carmen|||0000-0003-2180-1715
  • Mora Brugués, Josefina|||0000-0001-6777-5132
  • Platero, Judit|||0000-0001-6007-9855
  • Cruz-Lemini, Monica|||0000-0002-6807-3578
  • Llurba, Elisa|||0000-0003-4048-6407
  • García Osuna, Álvaro|||0000-0002-6682-0226
  • García Manau, Pablo|||0000-0002-2415-1626
  • Ullmo, Johana|||0000-0002-9313-917X
  • Sánchez García, Olga|||0000-0002-5279-440X
  • Vila-Cortés, M.
  • Pelegay, M. J.
  • Ricart, M
  • Muñoz-Abellana, B.
  • Barrios, X. Gabaldó
Objective: A soluble fms-like tyrosine kinase-1 (sFlt-1)-to-placental growth factor (PlGF) ratio cut-off of 38 is currently considered optimal for ruling out pre-eclampsia (PE); however, implementation of this ratio in clinical practice is limited. N-terminal pro B-type natriuretic peptide (NT-proBNP) is elevated in PE owing to the cardiovascular effects of this disease. This study aimed to identify the predictive performance of NT-proBNP to detect PE and placental complications within 1 week after assessment, and compare it with the predictive performance of the sFlt-1/PlGF ratio. High-sensitivity troponin T (hs-TnT) and uric acid were also evaluated. Methods: This was a prospective nested case-control study conducted in five Spanish centers between March 2018 and December 2020, and comprised women with a singleton pregnancy and suspected PE between 24 + 0 and 41 + 0 weeks' gestation. We evaluated the ability of the sFlt-1/PlGF ratio, NT-proBNP, hs-TnT and uric acid to predict the development of any-onset (at any gestational age), early-onset (before 34 weeks) or term (at or after 37 weeks) PE within 1 week or 4 weeks after assessment. Predictive performance was assessed by estimating negative predictive values, positive predictive values, sensitivity, specificity and areas under the receiver-operating-characteristics curves (AUCs) for these biomarkers, with corresponding 95% CIs. We performed post-hoc exploratory analyses of associations between the sFlt-1/PlGF ratio, NT-proBNP, hs-TnT and uric acid in women who developed PE, as well as in women who developed complicated PE (PE plus fetal growth restriction, stillbirth or placental abruption) within 1 week and 4 weeks after assessment. Results: A total of 323 women with suspected PE at or before 41 + 0 weeks were enrolled in the study, of whom seven were lost to follow-up. The final analysis included 316 eligible participants, with 424 samples. The overall incidence of PE was 23.4% (n = 74) and early-onset PE developed in 8.5% (n = 27) of cases. The sFlt-1/PlGF ratio and NT-proBNP exhibited similar abilities to predict early-onset PE within 1 week after assessment (AUC, 0.970 (95% CI, 0.932-1.000) and 0.971 (95% CI, 0.942-1.000), respectively). hs-TnT and uric acid demonstrated inferior predictive capability compared with the sFlt-1/PlGF ratio for the prediction of any-onset PE, early-onset PE and term PE within 1 week and 4 weeks after assessment. The optimal cut-off for NT-proBNP was 116 pg/mL. At this cut-off, NT-proBNP showed a sensitivity of 90.9% (95% CI, 70.8-98.9%) and a specificity of 94.3% (95% CI, 91.2-96.5%), with a positive predictive value of 5.7% (95% CI, 3.7-8.7%) and a negative predictive value of 99.9% (95% CI, 99.9-100%) in predicting early-onset PE within 1 week of assessment, which was comparable with that of the sFlt-1/PlGF ratio. Participants with PE-related complications had higher levels of all biomarkers, but only NT-proBNP showed a similar predictive ability to the sFlt-1/PlGF ratio for complicated PE within 1 week after assessment (AUC, 0.818 (95% CI, 0.706-0.930) vs 0.822 (95% CI, 0.723-0.921), respectively). Conclusion: An NT-proBNP cut-off value of 116 pg/mL has a similar diagnostic performance to that of the sFlt-1/PlGF ratio in predicting the diagnosis of early-onset PE within 1 week after assessment. Thus, NT-proBNP could be used in clinical practice for the early identification and management of PE, particularly in cases for which the sFlt-1/PlGF ratio is not available. © 2025 International Society of Ultrasound in Obstetrics and Gynecology.